Post-viral influenza Streptococcus pneumoniae pneumonia in an intravenous drug abuser

Sowjanya S Mohan1, Vinay Nair, Burke A Cunha

  • 1Infectious Disease Division, Winthrop-University Hospital, Mineola, New York 11501, USA.

Insights

This case study highlights a rare instance of severe Streptococcus pneumoniae community-acquired pneumonia (CAP) in a young intravenous drug abuser (IVDA) following influenza A infection. It underscores the potential for serious secondary bacterial pneumonia after viral influenza.

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Viral influenza, a common cause of community-acquired pneumonia (CAP), can be caused by influenza A or B.
  • Influenza A is often more severe in adults than influenza B.
  • Intravenous drug abusers (IVDAs) are susceptible to various infections but not typically viral influenza.

Observation:

  • A young IVDA presented with influenza A pneumonia.
  • The patient subsequently developed severe and prolonged Streptococcus pneumoniae CAP.
  • Complications included cavitation, empyema, pneumatoceles, and bronchopleural fistulae.

Findings:

  • This case represents the first reported instance of post-influenza pneumococcal pneumonia in an IVDA.
  • Pleural effusions from S. pneumoniae are uncommon, though empyemas are noted.
  • Tracheobronchial fistulae and cavitation are rare complications of S. pneumoniae CAP in adults.

Implications:

  • This case highlights unusual and severe complications of secondary bacterial pneumonia post-influenza in a vulnerable population.
  • It emphasizes the need for vigilance in diagnosing and managing secondary infections in IVDAs with influenza.
  • Further research may be warranted to understand the specific risks and management strategies for this patient group.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause: